A Phase 2 Study of AZD0530 in Metastatic Melanoma.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2014
At a glance
- Drugs Saracatinib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Jan 2011 Actual end date (January 2011) added as reported by ClinicalTrials.gov.
- 13 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.